Rationale Methylphenidate (MPH), the most widely prescribed psychostimulant to treat many neuropsychiatric conditions, is reported to improve attention and speed of processing in survivors of traumatic brain injury (TBI). The neural correlate of this efficacy, however, remains unclear.
Introduction
Traumatic brain injury (TBI) affects 1.5 million people each year in the USA alone and frequently results in debilitating and persistent cognitive impairment (Rutland-Brown et al. 2006; Whyte et al. 2004a) . Many patients live with deficits in higher cognition including attention and executive function for the rest of their lives (Jennett et al. 1981; Millis et al. 2001) . Methylphenidate (MPH) is the most widely prescribed psychostimulant and has been demonstrated to enhance cognition in many clinical populations as well as healthy individuals (Aman et al. 1984; Auriel et al. 2006; Rahman et al. 2006; Rapoport and Inoff-Germain 2002; Rhodes et al. 2004; Strauss et al. 1984; Turner et al. 2005) . MPH has also been tested in chronic survivors of traumatic brain injury (Siddall 2005; Sivan et al. 2010) . Improvements in processing speed and several attention measures have been reported by many researchers, including our group (Gualtieri and Evans 1988; Kaelin et al. 1996; Kim et al. 2006b ; Lee et al. 2005; Plenger et al. 1996; Whyte et al. 1997 Whyte et al. , 2004b .
Animal studies (for a review, see Challman and Lipsky 2000) have indicated that MPH improves cognition by increasing extracellular dopamine and norepinephrine in the cortical and subcortical regions (e.g., Berridge et al. 2006; Tye et al. 2010) . Research in healthy humans and individuals with disorders such as Attention Deficit Hyperactivity Disorder (ADHD) and cocaine addiction has suggested that the neural correlates of MPH efficacy may involve a complex set of mechanisms (for a recent review, see Swanson et al. 2011) . Previous neuroimaging studies reported that MPH could induce a reduction (e.g., Mehta et al. 2000; Volkow et al. 2008) , an enhancement (e.g., Bullmore et al. 2003; Goldstein and Volkow 2011; Goldstein et al. 2010; Li et al. 2010; Rubia et al. 2011; Shafritz et al. 2004 ), or both (e.g., Rubia et al. 2009; Tomasi et al. 2011 ) in task-associated activations/deactivations. In fact, the efficacy of MPH seems to be modulated by many factors including the types of cognitive tasks (e.g., Dodds et al. 2008) and the characteristics of participants tested (Clatworthy et al. 2009; Epstein et al. 2007; Vaidya et al. 1998) . Thus, more research with different tasks and populations is warranted to better understand the neural mechanism of MPH efficacy.
The current study is, to our knowledge, the first attempt to investigate the neural correlates of MPH efficacy in TBI. We aimed to examine the effects of single-dose MPH administration in chronic survivors of TBI with a randomized double-blind placebo-controlled crossover design. Continuous arterial spin labeled (CASL) perfusion functional magnetic resonance imaging (fMRI) (Detre et al. , 2009 Williams et al. 1992 ) was used to quantify cerebral blood flow (CBF) noninvasively. The fact that perfusion fMRI reliably measures physiologically meaningful baseline CBF across different time points (Wang et al. 2003b ) makes this technique well suited to examining neural responses to pharmacological agents in a crossover design. We validated the sensitivity of our perfusion fMRI method using sustained attention and working memory tasks in a previous study (Kim et al. 2006a) . Based on the results from previous studies of human subjects reviewed above, we initially hypothesized that the mechanism of MPH effects in TBI may involve modulations in regional brain activity associated with task performance. However, we were open to the possibility of an MPH effect outside the normal task-related areas because there can be brain reorganization after TBI.
Methods

Participants
Thirty-three participants with TBI were recruited from clinical databases of current and former patients at MossRehab (Schwartz et al. 2005) , as well as through community advertisement. To be included, participants had to be between the ages of 16 and 60, and to have a history of nonpenetrating traumatic brain injury of at least moderate severity at least 3 months prior to enrollment. Severity level was defined by a significant and well-documented loss or alteration of consciousness following injury (i.e., lowest Glasgow Coma Scale score of less than 12 or prospectively documented posttraumatic amnesia of greater than 1 day), or focal abnormality on a neuroimaging study that was attributable to traumatic injury. Self-or clinician-reported attention complaints were also required. Potential participants were excluded if they had a history of premorbid neurologic disease, psychosis, major affective disorder, developmental disability, ADHD, or if they were currently abusing alcohol or recreational drugs. Persons who were taking psychoactive medications other than anticonvulsants were excluded. During the study period, only psychoactive medications were monitored. Individuals who had a remote substance abuse with likely permanent organic sequelae judged by the study physician were also excluded. Individuals were excluded who had extensive focal lesions in the middle and inferior frontal cortices, which are frequently implicated in higher cognition including sustained attention or working memory.
Procedure
Participants and/or their involved caregivers (depending on the participant's cognitive capacity) provided informed consent. The study protocol was approved by the Albert Einstein Healthcare Network and the University of Pennsylvania IRBs. Participants with TBI were tested on two occasions, approximately 1 week apart at the same time of day. All participants were interviewed regarding their usual pattern of caffeine and nicotine intake. From this interview, a participant-specific agreement was reached to consume similar quantities of these substances on the two testing days. Participants consumed a capsule on each testing day that contained either placebo or MPH in a dose of 0.3 mg/kg rounded to the nearest 2.5 mg (as in Whyte et al. 2004b) , approximately an hour prior to testing, based on pharmacokinetic data on the peak drug effect. The order of drug vs. placebo was randomized, and both participants and investigators were blinded to the drug condition. Thirteen participants received the placebo condition first and then MPH. Blood pressure and pulse were assessed prior to drug administration and immediately following the scanning session to screen for adverse drug effects.
Cognitive tasks
Visual sustained attention task. A simple go/no-go visual reaction time task was used to examine the neural network involved in maintaining visual sustained attention (Whyte et al. 2004b; . Stimuli consisted of pairs of vertical lines presented for a brief period in the center of the screen. The central area of the screen was covered by a random pattern mask with a fixation cross except when a stimulus was presented. The mask subtended approximately 1°and 4°of horizontal and vertical visual angle, respectively. Subjects were taught that a pair of identical lines constituted a target, whereas a pair of grossly unequal lines constituted a foil (one line was the same length as the target and the other was 50% shorter), and to press the button with their dominant hand as quickly and accurately as possible in response to targets only. They were also explicitly told that only 20% of the stimuli were targets. A total of 60 stimuli were presented during an uninterrupted 6-min task block with an average interstimulus interval of 6 s (range, 4 to 8 s).
Two-back task. A letter version of two-back task (Awh et al. 1996; Cohen et al. 1997 ) was employed to examine the neural network involved in continuous performance of a working memory task. In this task, subjects were presented with a series of letters in the center of the screen. The letters subtended approximately 1.5°×1.5°of visual angle. Subjects were required to press the button whenever the letter presented was identical to the one presented two items previously in the sequence. A total of 180 letters were presented with an exposure duration of 1 s and an interstimulus interval of 2 s. The target rate for this task was 12%.
Data acquisition
All participants were trained on the study tasks outside the scanner prior to data collection to ensure comprehension of the instructions, adequate performance, and, in the case of the visual sustained attention task (VSAT), to select a participant-specific stimulus duration that resulted in approximately 75% accuracy. Details of the calibration procedure are available elsewhere (Whyte et al. 1995 ). The order of task blocks was always resting first, the sustained attention task second, and the two-back task last. Each task block was approximately 6 min, and the intervals between task blocks were approximately 30 s. During the resting condition, which was used as the baseline control, participants were instructed to close their eyes but stay awake. For both tasks, responses and reaction times (RTs) were recorded for further analysis.
Imaging was conducted on a Siemens 3.0 T Trio wholebody scanner (Siemens AG, Erlangen, Germany), using a standard transmit/receive head coil. An amplitudemodulated CASL technique was used for perfusion fMRI scans (Wang et al. 2005) . Interleaved images with and without labeling were acquired using a gradient echo echo-planar imaging sequence with the following acquisition parameters: field of view (FOV)022 cm, matrix064× 64, repetition time (TR)04 s, time to echo (TE)017 ms, flip angle090°. Fourteen slices (6-mm thickness with 1.5-mm gap) were acquired from inferior to superior in a sequential order to cover the whole brain supratentorially. A delay time of 1 s was inserted between the end of labeling pulses and image acquisition to reduce transit-related effects. Each subject performed three CASL scans each with 92 acquisitions (approximately 6 min). Before the functional scans, high-resolution T1-weighted anatomic images were obtained using 3D MPRAGE: TR01,620 ms, TI0950 ms, TE03 ms, flip angle015°, 160 contiguous slices of 1.0-mm thickness, FOV0192×256 mm 2 , matrix0192×256, 1NEX with a scan time of 6 min.
Data analysis
Behavioral data. Performance of the participants was characterized with respect to two dimensions: discrimination and speed. Discrimination was measured with d´. Speed was operationalized as median RT on hits (correct button presses to targets). In order to ensure that the scanning results reflected performance of the cognitive tasks as instructed, accuracy thresholds were set for inclusion in the final analysis. For both tasks, we required that accuracy was significantly above chance across the two sessions as measured by the binomial test.
Behavioral performance between drug conditions was compared with the Wilcoxon signed ranks test for each task. Statistical analyses were performed using PASW Statistics software version 18 (SPSS Inc., Chicago, IL, USA).
Imaging data. The location and extent of focal lesions was quantified by a trained observer under supervision of a neurologist (H.B.C.) with extensive experience in lesion assessment. Focal lesions included any cystic cavities and other focal regions of abnormal signal in the white or gray matter. For more technical details, see our previous study (Kim et al. 2008) .
Functional image pre-processing and individual-level analysis were carried out using VoxBo software (Center for Functional Neuroimaging, Philadelphia, PA, http:// www.voxbo.org). The group-level analysis was performed with Statistical Parametric Mapping software (SPM5, Wellcome Department of Cognitive Neurology, London, UK, http://www.fil.ion.ucl.ac.uk/spm). For each participant, functional images were realigned to correct the head motion using a six-parameter rigid-body least squares realignment routine (Friston et al. 1995) . If the average of the maximal translational displacements along the three axes (x, y, and z) during a session exceeded the average of voxel dimensions along the three axes, it was regarded as excessive motion. Perfusion weighted image series were generated by pairwise subtraction of the label and control images, followed by conversion to absolute CBF image series based on a single compartment CASL perfusion model (Wang et al. 2005) . The resulting CBF data sets contained 46 images for each 6-min task block with an effective TR of 8 s. The CBF images were then normalized to a custom template using symmetric normalization as implemented in the Advanced Normalization Tools (ANTS; http:// sourceforge.net/projects/advants). Normalized images were resampled to 3-mm isotropic cubic voxels. For detailed procedures for template building and spatial normalization, see our previous studies (Kim et al. 2008 (Kim et al. , 2010 ).
For each cognitive task, the following voxel-based statistical analyses were first conducted. For each subject, voxelwise individual general linear models (GLMs) were built to quantify CBF values for each task condition. The global signal covariate was included in the GLM to reduce spatially coherent noise in the data (Aguirre et al. 1998 ). Perfusion MRI data are known to be free from any substantial temporal autocorrelation (Aguirre et al. 2002; Wang et al. 2003a ). Therefore, no filtering, autocorrelation modeling, or smoothing was done for the time series. The resulting parameter estimates were then fed into a random effects model to allow population-level inferences (Holmes and Friston 1998) . For multiple comparison correction for our whole brain voxel-wise analysis, we adopted a family-wise error (FWE) corrected cluster-level threshold of p<0.01 after applying a peak height threshold of uncorrected p<0.001 for the voxel level. The resulting peak coordinates were mapped to MNI space by registering the custom template to the Colin brain (Van Essen et al. 2001 ) using ANTS. The anatomical labels of the peaks were manually obtained using the AAL atlas (Tzourio-Mazoyer et al. 2002) and an atlas by Mai and colleagues (2004) .
In addition, a region-of-interest (ROI) analysis approach was used to examine the MPH effects within the task-related brain networks for each task. This analysis strategy was chosen to increase the statistical power and to reduce Type I error (Poldrack 2007) . A priori ROIs were selected based on previous neuroimaging studies using visual sustained attention and N-back working memory tasks. For the visual sustained attention task, the following four ROIs in the AAL atlas (Tzourio-Mazoyer et al. 2002) were constructed based on previous studies of visual sustained attention (Coull et al. 1998; Kinomura et al. 1996; Lawrence et al. 2003; Lim et al. 2010) : bilateral anterior cingulate gyri, right lateral frontal cortex, right inferior parietal cortex including angular and supramarginal gyri, and bilateral thalami. For the twp-back task, the following ROIs were constructed based on a metaanalysis by Owen and colleagues (2005) : bilateral premotor areas including precentral gyri, bilateral lateral frontal cortices, bilateral thalami, and bilateral inferior parietal lobes including angular and supramarginal gyri. Because the ROIs were in the MNI space, ROIs were first warped to our custom template space using ANTS. Individual CBF time series were extracted from these ROIs for each subject and then averaged. Similarly, global CBF values were calculated from the CBF time series from a whole-brain gray matter mask. The mask was obtained by segmenting the custom template using SPM5. Global CBF values were compared across drug conditions with the Wilcoxon signed ranks test.
Results
Participant characteristics
Thirty-three individuals with TBI were originally enrolled in this study. Two individuals could not participate in the second session due to personal reasons that were not related to the study. Data from two participants were excluded due to data corruption. Two participants were excluded due to brain coverage issues after spatial normalization. Two participants had extensive focal lesions (greater than 50 cm 3 ) in the areas known to be involved in the tasks to be performed (middle and inferior prefrontal cortices). Motion during one or more task sessions resulted in the exclusion of an additional two participants from the VSAT task and four participants from the two-back task. In addition, five participants were excluded from the analysis of the VSAT task because their behavioral performance did not meet the necessary cutoff (see the "Data analysis" section). No one was excluded from the two-back task due to low performance. Because the participants with accuracy or motion exclusions differed between the two tasks, we chose to analyze slightly different participant samples for the two tasks. Consequently, the final analysis was conducted on 18 participants with TBI for the VSAT task and 21 participants for the two-back task. Tables 1 and 2 summarize the demographic and lesion characteristics of the TBI survivors who enter into either or both analyses.
MPH effects on task performance
For the VSAT, accuracy as measured by d´was significantly better, and median RT was significantly faster on MPH than on placebo. For the two-back task, the MPH resulted in significantly faster response time and a nonsignificant trend toward greater accuracy on MPH than on placebo (see Table 3 ).
MPH effects on CBF
Global resting perfusion. Table 4 presents global gray matter CBF values for each condition. For all task conditions, global CBF values on MPH were consistently lower than those on placebo. However, these differences did not reach statistical significance (see Table 4 ). This tendency of global reduction in CBF is consistent with results from previous studies that demonstrated vasoconstrictive properties of MPH (Wang et al. 1994) . Whole brain voxel-based analysis. Table 5 and Fig. 1 show the loci of activation and deactivation associated with the main effect of each task, which are generally in agreement with previous studies using similar tasks in healthy controls (Coull et al. 1998; Kim et al. 2006a; Lawrence et al. 2003; Owen et al. 2005; Pardo et al. 1991 Fig. 2 ). Subsequent analysis of mean CBF values from this area revealed that the interaction was mainly driven by a deactivation of this area during VSAT task performance on MPH. Furthermore, the magnitude of the parameter estimate for the interaction effecti.e., (task-rest on MPH) -(task-rest on placebo)-was correlated with MPH-induced reduction of RT (Pearson's r0−.48, p<.05).
A priori anatomical ROI analysis. As the "Method" section describes, four anatomical ROIs were identified as a priori regions of interest. Two analyses were conducted using these ROIs. First, we re-ran our voxelbased GLM analysis for the drug-related main and interaction effects within those ROIs. However, no voxel clusters survived after a multiple comparison correction for both tasks. Second, the average CBF values from each ROI were fed into a repeated measures ANOVA with three within-subject factors: task (rest, task), drug (placebo, drug), and region (four regions for each task). For the VSAT task, only the main effect of region was significant (F[3,51] 030.07, p<.001). For the two-back task, the main effects of region (F[3,60]0 66.19, p<.001) and task (F[1,20] 021.67, p<.001) were significant. No drug-related main and interaction effects were significant in either task (all p>.2). (Wang et al. 1994) . It was interpreted as vasoactive effects of the drug because CBF reduction was homogenous across regions. In line with the vasoactivity interpretation, a recent [ 18 F]FDG PET study (Volkow et al. 2008) reported that there were no regional MPH-induced metabolic changes at rest.
Against our initial hypothesis, we could not identify MPH-induced modulations of brain activity within the task-associated regions of interest, indicating that the drug's effects on perfusion were not task-dependent in these regions. However, a voxel-wise exploratory analysis identified a locus of the drug by condition interaction in the left posterior superior parietal lobule and parieto-occipital junction (BA 7/19) in the visual sustained attention task. Subsequent analysis of mean CBF values from this area revealed that the interaction was mainly driven by a deactivation of this area during task performance on MPH. Furthermore, the magnitude of the interaction was correlated with behavioral improvement on MPH, providing further evidence of its functional significance.
What might the significance of this MPH-induced reduction of left posterior parietal CBF be? If healthy subjects deactivate this area while performing the task, it could be concluded that MPH restores the normal suppression of activity in this area. If controls do not modulate this region during task performance, TBI survivors' MPH-induced deactivation might reflect a compensatory reaction to improve task performance. To answer this question, we looked at our previously published data on healthy controls (Kim et al. 2006a ). We noted that healthy control subjects showed neither activation nor deactivation in the superior parietal lobule with task performance. The same pattern is observed in this area of TBI patients: we could not detect a task-related CBF increase in patients even with a lowered threshold. These results suggest that suppression of activity in this area during task performance may instead be a compensatory mechanism by which MPH ameliorates attention impairments in TBI. This conclusion is in contrast with the majority of previous neuroimaging studies in ADHD and cocaine addiction that reported MPH-induced "normalization" of altered task-related regional activity (Goldstein and Volkow 2011; Goldstein et al. 2010; Rubia et al. 2009 Rubia et al. , 2011 Shafritz et al. 2004) . One potential explanation is that TBI is associated with a larger degree of brain reorganization, mandating a compensatory mechanism of recovery.
Why is suppression of the posterior superior parietal cortex associated with improved performance? One explanation is based on the animal (e.g., Colby et al. 1988 ) and human (e.g., Portin and Hari 1999) studies reporting that the parieto-occipital area preferentially represents the peripheral visual field (cf. Palmer and Rosa 2006) . Thus, suppression in this area might reflect increased focused attention on the stimulus at the center of the visual field. We further speculate that control subjects might not have deactivated this region during the task because their attentional capacity was not depleted to the level where deactivation of this region is required. Another explanation is that the superior parietal cortex is a part of the resting state network the activity of which may be suppressed when the brain is engaged in an active cognitive task. In fact, this area has Mean and standard deviation, in parenthesis, of behavioral measures are reported with corresponding within-subject effect sizes defined by Morris and DeShon (2002) Mean and standard deviation, in parenthesis, of CBF values are reported with corresponding within-subject effect sizes defined by Morris and DeShon (2002) been identified as part of "left parietal-frontal resting-state network" (Beckmann et al. 2005; Damoiseaux et al. 2006; van den Heuvel et al. 2008) . However, the exact behavior and the functional meaning of this network remain unclear (van den Heuvel and Hulshoff Pol 2010) . Still another interpretation is based on the studies proposing posterior superior parietal cortex as part of the dorsal attention system that helps select features of interest (Behrmann et al. 2004; Corbetta et al. 2008; Corbetta and Shulman 2002) . Thus, decreased CBF during task performance in this area on MPH might reflect increased efficiency of the dorsal attention system. This explanation is in line with some previous studies of MPH efficacy in healthy subjects (Mehta et al. 2000; Volkow et al. 2008) . However, this interpretation cannot explain why the CBF level in this area during the task dropped further below the level of resting after MPH administration. A fourth potential interpretation is based on the studies showing that deactivation in the superior parietal area has been associated with the state of meditation (Newberg et al. 2001; Newberg and Iversen 2003; Wang et al. 2011 ). Similar to the beneficial effect of meditation, an increased ability to focus during sustained attention performance on MPH might have prevented "mind wandering," consequently facilitating task performance. This interpretation might also explain the fact that this area was not deactivated on MPH during the two-back task, since the fast-paced nature of the working memory task, itself, might have prevented mind wandering. Unfortunately, our current limited knowledge does not allow us to preferentially choose one explanation over the others. We expect that further research on the role of this area will shed light on our empirical finding in the future. Several potential limitations of the current study should be noted. First, the order of task blocks was not counterbalanced. The sustained attention task was always administered before the two-back task. For this reason, task order effects cannot be ruled out when comparing the results from the two tasks. This time confound could be an alternative explanation why we observed stronger behavioral enhancement in the sustained attention task compared to the twoback task. Another limitation of the study is the relatively noisy nature of ASL time series. Despite using lenient thresholding for examining perfusion fMRI results, a low signal-to-noise ratio could have prevented identification of other brain regions showing MPH effects. Third, the group analysis approach we took might have overlooked individual-specific patterns of reorganization in brain activation. Fourth, one should be reminded that the present study used a blocked design with a very long task period, so that brain activation likely reflected primarily enduring aspects of "task set," rather than transient neural events associated with stimulus processing and response. While this design allows us to detect tonic cognitive components with increased sensitivity, effects of MPH on these more transient cognitive processes may have been missed. Finally, a relatively small sample size could have reduced the statistical power to detect the effects of interest.
In conclusion, our perfusion fMRI study confirmed the effect of MPH on performance of higher cognitive tasks in chronic TBI and identified a locus of the MPH effect in the left posterior superior parietal area. The magnitude of taskrelated tonic CBF reduction in this area was correlated with improvement in performance. The fact that healthy controls did not activate this region during task performance suggests that suppression of activity in this area may reflect a TBI-specific mechanism by which MPH ameliorates attention impairments. In future studies, the significance of the left posterior parietal area for modulating sustained attention in TBI could be confirmed by using transcranial magnetic stimulation to suppress its activity. A study implementing both BOLD and perfusion fMRI would also be useful in investigating both tonic and transient components of higher cognition in TBI.
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Conflict of interest The authors declare that there are no other potential conflicts of interest related to this study. Fig. 2 The Drug by condition interaction for the sustained attention task and relationship with behavior. (Left) An interaction effect of drug by condition (MPH-placebo X VSAT-rest) was located in the left posterior superior parietal lobule. (Middle) An ROI analysis indicated that the interaction was due to a deactivation of the area during task performance on MPH. (Right) Relationship between the magnitude of the deactivation and MPH-induced RT reduction. Each individual's median RT was transformed to a z-score based on the group mean before ΔRT (drug-induced RT change) was calculated. ΔRTs were flipped along the y-axis so that positive numbers represent improvement in speed. Brain images are in radiological convention
